Modulations of the Activity of Blood Coagulation Factor Viii and Screening Coagulogram in Patients With Hemophilia When Performing Knee Joint Endoprosthesis

Hematology & blood transfusion: interdepartamental collection
doi 10.33741/0435-1991.40.05
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Institute of Haematology and Transfusiology of the National Academy of Medical Sciences of Ukraine

Related search

Features of Factor VIII Activity Measurement in Arg531His Mutant Detected in Patients With Mild Hemophilia A

Japanese Journal of Thrombosis and Hemostasis
2008English

Survival of 125iodine-Labeled Factor VIII in Normals and Patients With Classic Hemophilia. Observations on the Heterogeneity of Human Factor VIII.

Journal of Clinical Investigation
Medicine
1978English

Elevated Coagulation Factor VIII Plasma Activity in a Patient With Lymphangiosarcoma

Internal Medicine
Internal MedicineMedicine
2012English

Prevalence of Inhibitors to Factor VIII After 25 Exposures to Factor VIII Concentrates and/or Blood Products in Persons With Hemophilia A

Journal of Medical Science And Clinical Research
2017English

Hemophilia as a Defect of the Tissue Factor Pathway of Blood Coagulation: Effect of Factors VIII and IX on Factor X Activation in a Continuous-Flow Reactor.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1990English

Long-Term Expression of Human Coagulation Factor VIII and Correction of Hemophilia a After in Vivo Retroviral Gene Transfer in Factor VIII-deficient Mice

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1999English

The Impact of Factor VIII/von Willebrand Factor Products in Inhibitor Development and Management of Patients With Hemophilia a With Inhibitors

Oncology & Hematology Review (US)
2007English

AMulticenter Clinical Study of Recombinant Factor VIII (BL-160) in Hemophilia a Patients

Japanese Journal of Thrombosis and Hemostasis
1993English

Factor VIII Associated With Lipidic Nanoparticles Retains Efficacy in the Presence of Anti-Factor VIII Antibodies in Hemophilia a Mice

Biopharmaceutics and Drug Disposition
MedicinePharmacologyPharmaceutical Science
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy